Clinical Trial Update: Examination the Ability to Early Diagnose HCC by Combining Three Biomarkers Technology Developed by WAKO, And Their Relevance to Cirrhotic of Patients With Various Backgrounds and the Israeli Population. [NA]

View source ↗

Summary

This update describes a clinical trial evaluating a three-biomarker approach developed by WAKO to enable early diagnosis of hepatocellular carcinoma in cirrhoti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma
• Liver Cirrhosis

Snippet

Sponsor: Ilex Medical | Conditions: Fibrosis | NA | Status: UNKNOWN